Members of Systemic Therapeutics attended the Stanford Drug Discovery Symposium 2024 from April 29 - 30.

This study demonstrates that the neuroprotection of coffee on PD is attributed to caffeine and its metabolites.

Mounting evidence suggests that drinking several cups of tea per day has numerous health benefits.

Evidence suggests that caffeine reduces cardiovascular disease risk.

Drinking a few cups of coffee each day can potentially reduce the risk of death from cardiovascular disease.

Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system.

Scientists from Systemic Therapeutics Corp. have a new understanding of the protective effects of caffeine on the cardiovascular system.

Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system.

Scientists from Systemic Therapeutics Corp. have a new understanding of the protective effects of caffeine on the cardiovascular system.

Evidence suggests that caffeine (CF) reduces cardiovascular disease (CVD) risk.

Systemic Therapeutics Corp. (the "Company" or "SystemicTx") is a pre-clinical stage, biotechnology company.

We have uncovered a cochaperone function for PCSK9Q152H that explains its hepatoprotective effects.